AbbVie   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Lake Bluff IL United States (2013)

Organization Overview

First Clinical Trial
2013
NCT00195663
First Marketed Drug
2013
dicoumarol
First NDA Approval
2014
paritaprevir (viekira pak)
Last Known Activity
2024

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Abbvie | AbbVie | ABBVIE | AbbVie AB | AbbVie Clinical Pharmacology Research Unit (ACPRU) | AbbVie Corporation | ABBVIE ENDOCRINE | ABBVIE ENDOCRINE INC | AbbVie GK | AbbVie GK. | AbbVie Inc. | ABBVIE INC | AbbVie Japan | AbbVie Japan Co., Ltd | AbbVie Laboratories | AbbVie LC | AbbVie (prior sponsor, Abbott) | AbbVie_Stemcentrx | AbbVie Study-Designated Physician | Medical Affairs, AbbVie Sweden AB | ORGANICS LAGRANGE